NYSE:PRGOPharmaceuticals
Perrigo (PRGO) Valuation In Focus As Infant Formula Class Action Lawsuits Gain Momentum
Several class action lawsuits tied to Perrigo (PRGO) and its acquired Nestlé infant formula business have moved into focus as lead plaintiff deadlines approach, putting legal risk and disclosure practices front and center for shareholders.
See our latest analysis for Perrigo.
At a share price of US$15.03, Perrigo’s recent 13.61% 1 month share price return contrasts with a 30.74% 3 month decline and a 33.39% 1 year total shareholder return loss. This suggests sentiment has been fragile as...